SA, I think that is the problem that ENZC shareholders are facing moving forward. I believe that all PR's, especially any that will really move the needle, will be PR'd under BGEN, VIRO, or even held back until the SAGA deal is done, then PR'd under SAGA. I genuinely don't believe we'll see anything major (C3 cured ENZO/HIV, etc...) PR'd under ENZC.
I'm not sure if you noticed, the past couple of PR's that we've seen, are being published as VIRO or BGEN, instead of ENZC. They mention ENZC by saying "wholly owned by ENZC," but these PR's used to come out in reverse. They'd pr under ENZC, then give the info about the subs and what they've done/working on, but ENZC always took the lead. The fact that they've changed/reversed this, and now PR under BGEN/VIRO and/or BGEN/VIRO take the lead, then mention ENZC within the PR, tells me they have begun the shift. In other words, I'm not expecting any major/significant future PR's coming out under ENZC, except the one that says the SAGA deal is complete and BGEN/VIRO have been sold to them.
I know I'll be called a bear, etc... for this, but that's ok. I'm just reading between the lines and noticing the subtle differences...
News 
Market Data 
Discover 
AI
